Last updated: April 11, 2024
Sponsor: University of California, Berkeley
Overall Status: Active - Recruiting
Phase
1
Condition
Aging
Treatment
Nicotine gum
Placebo gum
Clinical Study ID
NCT05018117
2018-12-11682
R01AG067073-01A1
Ages 18-85 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- non-smokers with a score of 0-2 out of 10 maximum on the Fagerström index of smokingdependency
Exclusion
Exclusion Criteria:
- deafness or excessive hearing loss
- smokers with a score between 3 and 10 on the Fagerström index of smoking dependency
- history of psychiatric illness, neurological disorders, diabetes mellitus, renalfailure, or cardiovascular disease
- regular use of prescription medications (excluding oral contraceptives)
- drug dependency
Study Design
Total Participants: 48
Treatment Group(s): 2
Primary Treatment: Nicotine gum
Phase: 1
Study Start date:
June 06, 2022
Estimated Completion Date:
December 31, 2025
Connect with a study center
University of California, Berkeley
Berkeley, California 94720
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.